Got to love this bit that was published in the Adelaide Advertiser yesterday reporting on the results....
"Invion is targeting a multi-billion dollar market segment that already has two existing drugs - from GlaxoSmithkline and Pfizer. However, the results from Invion's study indicate its success rate is in the ballpark with that of the two pharma majors offerings, but has lower side-effects, Dr Collier said."
The press out there is good
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.015(12.0%) |
Mkt cap ! $9.320M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.5¢ | 10.5¢ | $10.86K | 91.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 72689 | 2 |
View Market Depth
| Last trade - 13.08pm 25/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |